edited by Hiroshi Mitsumoto, MD, and Theordore L. Munsat, MD, 2nd ed, 472 pp, with illus, $39.95, Demos, New York, NY, 2001.
The incidence of amyotrophic lateral sclerosis (ALS) is higher than is generally recognized—about two thirds that of multiple sclerosis. During the last 2 decades, this has been realized by professionals and the public, and has resulted in the development of an increasing number of neurological centers specializing in the care of patients with ALS and their families (ALS is truly a disease that affects the whole family unit). The increased number of centers has been associated with more clinical research on ALS—its etiology, diagnosis, management, and treatment. The 1990s saw more articles and more meaningful advances in our understanding of ALS then had any decade preceding it.
Bradley WG. Amyotrophic Lateral Sclerosis: A Guide for Patients and Families. Arch Neurol. 2002;59(7):1200. doi:https://doi.org/
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: